No photo of Guillermo Montoya
  • Source: Scopus
20082024

Research activity per year

Personal profile

Current research

  • Molecular activation mechanisms of oligomeric kinases involved in genome integrity
  • Protein complexes involved in telomere maintenance and integrity
  • Conformational activation of CRISPR-Cas12a catalysis and its redesign to generate new molecular scissors
  • Mechanisms for foreign RNA and DNA degradation by macromolecular complexes

 

 

CV

Guillermo Montoya

Current position

Jan. 2014–:

Professor and research director, Protein Structure & Function Program, CPR, University of Copenhagen, Denmark


Previous positions

2008–2015:

Group leader, Spanish National Cancer Research Centre (CNIO), Madrid, Spain

2003–2006:

Acting director, Structural Biology Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain

2000–2002:

Research associate, European Molecular Biology Laboratory (EMBL) Heidelberg, Germany

1994–1999:

EMBO & Marie Curie fellow, EMBL Heidelberg, Germany

1998:

Investigator, Spanish National Research Council (CSIC), on leave at EMBL Heidelberg, Germany

1993–1994:

EMBO & FEBS fellow, Max Planck Institute of Biophysics, Frankfurt am Main, Germany

 

Education

1989–1993:

PhD in Chemistry, University of Zaragoza, Spain.
Thesis title: Characterization of sugar beet photosystem II reaction center using LASER picosecond flash photolysis spectroscopy

1984–1989:

MSc in Biochemistry, University of the Basque Country, Leioa, Spain

 

Research awards

2018:

Elected member of the European Molecular Biology Organization (EMBO)

2016–:

Chairman of ISBUC, the Integrative Structural Biology Cluster at UCPH

2009:

Spanish National Prize in Biomedicine from the Fundación Mutua Madrileña

V Health Sciences Prize from Caja Rural de Granada-Ministerio de Sanidad

Mar. 2000:

Peter und Traudl Engelhorn Foundation Fellowship

Mar. 1997:

Postdoctoral fellowship of the Spanish Ministry of Education and Science

Feb. 1995:

Marie Curie Fellowship of Human Capital and Mobility Program of the European commission

1994:

EMBO long-term fellowship, funded directly for 2 years due to being placed second in the Feb. 1994 evaluation

1993:

EMBO short-term fellowship, Frankfurt am Main

1993:

FEBS short-term fellowship, Frankfurt am Main

Spanish National Prize in Biomedicine from the Fundación Mutua Madrileña

Short presentation

Professor Guillermo Montoya is Research Director and Group Leader at the Protein Structure and Function program at Novo Nordisk Foundation Center for Protein Research (CPR) at University of Copenhagen.
Guillermo Montoya’s research aims to understand basic cellular mechanisms at the atomic level, and he firmly believes that the detailed unravelling of these mechanisms will be essential for future biomedical research.
The approach of the Montoya Group is to use advanced methodology, combining X-ray crystallography and cryo-electron microscopy with cell biology to study the structure and function of macromolecules involved in cell cycle progression, genome integrity and its manipulation.

 

Key discoveries

Montoya solved the first crystal structure of the 1 MDa TRiC/CCT chaperonin in complex with tubulin, shedding light on the folding mechanism that is essential for cell cycle progression and chromosome segregation. His group has recently provided molecular evidence of how key guardians of genome integrity such as the kinase TLK2 or the XMAP215 microtubule polymerase work to protect the genome and provide faithful cell division.

Montoya is also systematically pursuing the structure-function analysis of endonucleases, which are of great interest because of their applications in genome editing. His seminal work in homing endonucleases has shown that these proteins were amenable of redesign in order to target mutations in human monogenic diseases.

His studies elucidating the structure of CRISPR-Cas12a interference ribonucleoprotein have unveiled the mechanism of recognition, unzipping and catalytic activation in order to cleavage target DNA. This finding has opened new avenues in genome modification for biomedicine and biotechnology.

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or